HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

11th Edition of International Conference on
Dental Innovations and Technologies

March 19-21, 2026 | Singapore
Dental 2022

Development of innovative Dental products: From concept to consumer

David Geoffrey Gillam, Speaker at CE Accredited Dental Conferences
Queen Mary University of London, United Kingdom
Title : Development of innovative Dental products: From concept to consumer

Abstract:

The development of products for the dental market is a complex process requiring numerous stages of development from the laboratory to the clinical or consumer environment. There is no guarantee of success since very few products enter into the consumer market. The aim of this presentation is to update participants on the novel products that have been developed in a university environment and successfully launched into both the consumer and clinical environment. One of these products is a bioactive glass (BioMinF®) which has been optimized specifically for use as an additive for toothpaste in the treatment of dentine hypersensitivity and remineralization of the early caries lesion. Following laboratory evaluation and subsequent clinical trials the product is now classed as medical device (Class IIb) and distributed in numerous countries. Other products have been developed include Biomin C (Chloro Calcium Phosphosilicate: a non-fluoride toothpaste), an adhesive orthodontic varnish and a fluoride toothpaste for professional use (Dr Collins BioMin® Restore Plus, USA). The advantage of the bioactive glass product is that it enables the fluoride within the glass to dissolve into the saliva over time (up to twelve hours) and provides a fluorapatite layer on the tooth surface that is resistant to acid attack.

Biography:

David Geoffrey Gillam graduated from Edinburgh Dental School in 1977 and has been actively involved in Dentistry for over 45 years. He has worked in both clinical practice and university dental hospitals, as well as in industry (1998-2001), initially with SmithKline Beecham and later with Block Drug Company. From 2003 to 2008, he worked with a Clinical Research Organization as a Research Dentist. He also served as a full-time Clinical Reader (Associate Professor) in Translational Research related to Dentistry at Bart’s and The London School of Medicine and Dentistry, QMUL in London (2009-2022). Currently, David is a part-time Professor at QMUL, although he no longer practices dentistry. His primary research interest lies in Periodontology, particularly the management of dentine hypersensitivity, and he has also developed an interest in the development of dental materials for both professional and consumer use. David has published over 100 papers on various dental topics and has contributed to several books, both as an Editor and as a chapter contributor.

Watsapp
a